Company Active PRIVATE-UNLIMITED

Company profile

Glaxosmithkline Services Unlimited

Patient Welcome Page

Glaxosmithkline Services Unlimited is a UK company with status active founded in 1972 based in London.

CRN
01047315
Founded
1972
Age
54

Overview

Legal name
GLAXOSMITHKLINE SERVICES UNLIMITED
Region
London
Registered address
79 NEW OXFORD STREET
LONDON
UNITED KINGDOM
WC1A 1DG
Insolvency history
No

Corporate ownership

Updated 06 Jun 2026 16:52

1 level 1 ultimate controller
1
Company Active PRIVATE-UNLIMITED
Glaxosmithkline Services Unlimited
CRN 01047315
2
Direct and ultimate controller Active PLC
GSK PLC
CRN 03888792

Company events

Reference milestones and recent Companies House filing stream events.

11 events
04 May
2027

Confirmation statement due

Confirmation Due

Next confirmation statement due date

20 Apr
2026

Confirmation statement filed

Confirmation

Last confirmation statement made up date

31 Dec
2024

Accounts filed

Accounts

Last accounts made up date

23 Sep
2024

Change Person Secretary Company With Change Date

Officers

CH03 | Transaction MzQzNjY4MTA0NmFkaXF6a2N4

Published 23 Sep 2024 06:42

23 Sep
2024

Change Person Director Company With Change Date

Officers

CH01 | Transaction MzQzNjY4MTEwMWFkaXF6a2N4

Published 23 Sep 2024 06:36

17 Sep
2024

Change Person Director Company With Change Date

Officers

CH01 | Transaction MzQzNjAyNjc4M2FkaXF6a2N4

Published 17 Sep 2024 06:29

11 Sep
2024

Change To A Person With Significant Control

Persons-with-significant-control

PSC05 | Transaction MzQzNTI0NDMyNmFkaXF6a2N4

Published 02 Oct 2024 01:56

11 Sep
2024

Change Registered Office Address Company With Date Old Address New Address

Address

AD01 | Transaction MzQzNTIyMjQxNmFkaXF6a2N4

Published 11 Sep 2024 02:01

04 Sep
2024

Accounts With Accounts Type Full

Accounts PDF pending

AA | Transaction MzQzNDMxMjM2N2FkaXF6a2N4 | Paper/PDF filed

Published 06 Sep 2024 11:26

15 Aug
2024

Confirmation Statement With No Updates

Confirmation-statement

CS01 | Transaction MzQzMjMzNzY3NmFkaXF6a2N4

Published 15 Aug 2024 10:12

23 Mar
1972

Incorporated

Inception

Company registered at Companies House

Public funding

4 awards
First funded
2013
Funded years
2013, 2014, 2025
Age at first award
41 years

Projects

2025 Feasibility Studies

Optimising Energy Efficiency for Sustainable Medicines Manufacturing

1 Jan 2025 to 31 May 2025

Awarded
£0
Total cost £18,164

This project introduces an innovative, large-scale approach to reducing energy consumption within the UK's medicines manufacturing sector, a sector that faces unique sustainability challenges due to its energy-intensive processes and stringent regulatory requirements. The project focuses on Productivity and Resource Efficiency, aiming to significantly low...

2014 Collaborative R&D

Accelerating paediatric formulation development through smart design and predictive science

1 Jul 2014 to 31 Mar 2018

Awarded
£70,959
Total cost £141,918

This project is a collaboration between large UK pharmaceutical companies, academia and technology suppliers to generate a structured approach to designing age-appropriate medicines for children and technology for predicting their quality and performance. Paediatric medicine is currently a "hot-topic" within the pharmaceutical industry and there is a lot ...

2014 Collaborative R&D

Digital Design of Drug Products

1 Jun 2014 to 31 May 2016

Awarded
£30,204
Total cost £60,408

This project brings together experts in drug development, product formulation, process design, systems modelling and manufacture to create a completely new approach to the design and manufacture of formulated drug products, which involves the integration of qualitative tools for process understanding with a range of in-silico models which describe and pre...

2013 Collaborative R&D

Development of an Innovative Modular System for Continuous Chemical Processing

1 Apr 2013 to 30 Sep 2016

Awarded
£10,000
Total cost £100,284

The project, lead by Syrris, in collaboration with GSK, AMRI UK and the EPSRC Centre for Innovative Manufacturing in Continuous Manufacturing and Crystallisation will develop an innovative modular system for continuous chemical processing. It will develop modules that can be used by any chemical industry to perform unit operations such as liquid-liquid, l...

Product types

Collaborative R&D Feasibility Studies